Genzyme (also known as Genzyme Transgenics Corp or GTC Biotherapeutics) was an American biotechnology company based in Cambridge, Massachusetts. From its acquisition in 2011 to …

Feb 3, 2022 · Eleven years after Sanofi bought Genzyme for about $20.1 billion, the parent company said Thursday it will no longer call its specialty care unit Sanofi Genzyme ― just …

Jan 21, 2025 · French drugmaker Sanofi received a warning letter from the US Food and Drug Administration (FDA) last week for failing to comply with its current good manufacturing …

Genzyme Corporation is a leading biotechnology company that focuses on five business areas: therapeutics, diagnostic services, diagnostic products, pharmaceutical and fine chemicals, and …

Feb 26, 2024 · A manufacturing problem from 15 years ago and the resulting prolonged drug shortage is at the heart of newly revived litigation against Sanofi’s Genzyme. An appeals court …

Jan 21, 2025 · Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a U.S. drug ingredients plant tied to its longstanding …

Jan 22, 2025 · The FDA has issued a warning letter to Sanofi’s Genzyme facility in Framingham, Massachusetts, citing multiple manufacturing violations. Despite the regulatory scrutiny, Sanofi …

Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. It is …

French drugmaker Sanofi-Aventis SA clinched its long-sought deal for Genzyme Corp with a sweetened $20.1 billion cash offer, plus payments tied to the success of the U.S. biotech …

Aug 1, 2014 · Genzyme Corporation manufactures, markets and/or distributes more than 10 drugs in the U.S.